Thymosin Alpha1
Sponsors
Wen-hong Zhang, RenJi Hospital, Sun Yat-sen University, Fudan University, Nanjing Medical University
Conditions
Cardiopulmonary BypassChronic Hepatitis bImmunotherapyIrAELong-term Effects of Thymosin Alpha 1 TreatmentNon Small Cell Lung CancerNon-small Cell Lung CancerOsteoporotic Pain
Phase 2
Phase 3
Phase 4
Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients
NCT03448744
Start: 2017-10-25End: 2018-12-30Target: 240Updated: 2018-02-28
Immunotherapy for Elderly Patients With Chronic Osteoporotic Pain
NCT04524169
Start: 2020-11-01End: 2021-12-31Target: 100Updated: 2020-08-26
Thymosin Alpha-1 for irAE Secondary to ICIs
NCT06178146
Start: 2023-09-01End: 2025-04-30Target: 40Updated: 2023-12-20
Unknown Phase
Long-term Prognosis of Patients With Sepsis After Immunotherapy
Not yet recruitingNCT04901104
Start: 2021-07-01End: 2027-03-31Target: 900Updated: 2021-05-25
Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass
NCT05487469
Start: 2022-07-01End: 2023-12-31Target: 200Updated: 2022-08-04
Immuno-effect of Tα1 for Stage I NSCLC
RecruitingNCT06598839
Start: 2024-06-30End: 2025-12-30Target: 40Updated: 2024-09-19